Overall rank by patents
#37,422
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).
The verdict
Simplivia holds 7 US patents across 3 technology areas, rank #37,422 of 50,000 tracked assignees.
Simplivia Healthcare Ltd. has been granted 7 US utility patents between 2020 and 2023, placing Simplivia Healthcare Ltd. at rank #37,422 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.7 claims per patent with primary concentration in A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). As a Foreign Corporation, Simplivia Healthcare Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Simplivia sits between Silicon Biosystems S.p.a. (7 patents, rank #37,418) and Singularity Ag (7 patents, rank #37,426) - the closest US assignees by grant volume. The composite Innovation Score of 31.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Simplivia Healthcare Ltd.'s 14.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Simplivia Healthcare Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SILICON BIOSYSTEMS S.P.A.
7 patents
SILMACH
7 patents
SILVER CROSS (IP) LIMITED
7 patents
SIMPLICITY WORKS EUROPE, S.L.
7 patents
SIMPSON BIOTECH CO., LTD.
7 patents
SIMU
7 patents
SIMUR, INC.
7 patents
SINGULARITY AG
7 patents
SIMPLIVIA HEALTHCARE LTD.
7 patents
What this shows Simplivia holds 7 patents at rank #37,422, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #37,422 in granted patent volume.
Other assignees with the most granted patents in Simplivia's primary technology class.
Simplivia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 64% higher than 36% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 28.6% |
| 2021 | 1 | 14.3% |
| 2022 | 3 | 42.9% |
| 2023 | 1 | 14.3% |
Top 3 of 3 technology areas
Overall rank by patents
#37,422
Across all tracked assignees
31.0 out of 100
How to use this portfolio
Simplivia's 7 grants land it in the top 64% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.